Abstract 186: CD36 Antagonism Minimizes Skin Scarring By Inhibiting JUN-dependent Fibrotic Pathways Within Fibrogenic Fibroblast Subpopulations

by Mimi R. Borrelli, MBBS, MSc, Julia Garcia, PhD, Michelle Griffin, MD, PhD, Nestor M. Deleon Diaz, Alexandra L. Moore, MD, Shamik Mascharak, MS, Bryan Duoto, MS, Heather desJardins-Park, Sandeep Adem, MS, Tristan Lerbs, PhD, Marc Gastou, PhD, Lui Cui, PhD, Michael Januszyk, MD, PhD, Hermann P. Lorenz, MD, Derrick C. Wan, MD, Geoffrey C. Gurtner, MD, Howard Chang, MD, PhD, Gerlinde Wernig, MD, Michael T. Longaker, MD, MA
Published 2020-04-01